Amgen offers $167m for drug discovery biotech Nuevolution

Amgen offers $167m for drug discovery biotech Nuevolution

Source: 
Pharmaforum
snippet: 

Amgen has agreed to buy Swedish biotech Nuevolution for around $167 million to boost its drug pipeline after an R&D collaboration showed promise.